Cipla remains in focus after analysts revised their target price downward, citing short-term supply challenges affecting key products. The revision reflects cautious near-term expectations.
Despite this, the company continues to maintain strong long-term growth potential due to its robust product pipeline and expanding global presence.
Investors are closely watching developments, as operational improvements could drive future performance.
